The ATS Research Award in Interstitial Lung Disease from the American Thoracic Society (ATS) is sponsored by Boehringer Ingleheim Pharmaceuticals, Inc. and supports research on the rare disease Interstitial Lung Disease (ILD) by early-stage investigators. Applicants must be early-career researchers (within 12 years of completing their terminal degree) or trainees (fellows) and members of ATS. Applicants may be based at any qualified research institution in the USA. The Award provides 50,000 USD/year for 1 year (no indirect costs).
Applications open on July 17, 2023 and close on January 8, 2024.
January 8, 2024